ResMed to Report First Quarter Fiscal 2022 Earnings on October 28, 2021
07 Outubro 2021 - 05:05PM
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release
financial and operational results for the first quarter of fiscal
year 2022 on Thursday, October 28, 2021, after the New York Stock
Exchange closes. Following the release, ResMed management will host
a webcast to discuss these results. Other forward-looking and
material information may also be discussed during this webcast.
Earnings webcast
details: |
• |
Location: |
http://investor.resmed.com |
• |
Date: |
Thursday, October 28,
2021 |
• |
Time: |
1:30 p.m. PDT / 4:30 p.m.
EDT |
• |
International: |
London, Thursday, October 28,
9:30 p.m. BST |
|
|
Sydney, Friday, October 29,
7:30 a.m. AEDT |
|
|
|
Please note that ResMed does not use outside phone lines to
access the earnings call.
A replay of the earnings webcast will be accessible on ResMed’s
website and available approximately two hours after the webcast. In
addition, a phone replay will be available approximately two hours
after the webcast and will be accessible from October 28 until
November 11 at:
• |
U.S.: +1 877.660.6853 |
• |
International: +1
201.612.7415 |
• |
Conference ID: 13723324 |
|
|
About ResMedAt ResMed (NYSE: RMD, ASX: RMD) we
pioneer innovative solutions that treat and keep people out of the
hospital, empowering them to live healthier, higher-quality lives.
Our digital health technologies and cloud-connected medical devices
transform care for people with sleep apnea, COPD, and other chronic
diseases. Our comprehensive out-of-hospital software platforms
support the professionals and caregivers who help people stay
healthy in the home or care setting of their choice. By enabling
better care, we improve quality of life, reduce the impact of
chronic disease, and lower costs for consumers and healthcare
systems in more than 140 countries. To learn more, visit
ResMed.com and follow @ResMed.
For investors |
For media |
Amy Wakeham |
Jayme Rubenstein |
+1 858.836.5000 |
+1 858.836.6798 |
investorrelations@resmed.com |
news@resmed.com |
ResMed (NYSE:RMD)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
ResMed (NYSE:RMD)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024